Lexicon Pharmaceuticals Inc (LXRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

8800 TECHNOLOGY FOREST PLACE THE WOODLANDS, TX 77381

Operates as a biopharmaceutical company that discovers and develops breakthrough treatments for human disease. The company uses gene knockout technology to systematically discover the physiological functions of genes in living mammals, or in vivo.

Data based on most recent fiscal year report
Market Cap904.906 Million Shares Outstanding105.59 Million Avg Volume1.202 Million
1-Yr BETA vs S&P TR1.609 Current Ratio2.59 Quick Ratio2.58
View SEC Filings from LXRX instead.

View recent insider trading info

Funds Holding LXRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LXRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DEBBANE RAYMOND

  • Director
35,398 2019-12-30 3

SOBECKI CHRISTOPHER J

  • Director
55,447 2019-12-30 3

NORTHCOTT JOHN SVP & CHIEF COMMERCIAL OFFICER

  • Officer
200,000 2019-12-02 0

GREGORY JULIA P

  • Director
0 2019-11-22 0

BANSAL AJAY PFO;CFO/UROVANT SCIENCES, INC.

  • Officer
75,000 2019-11-05 0

CRUM BRIAN T VP, GENERAL COUNSEL & SECR.

  • Officer
22,925 2019-10-28 1

HOWSON TAMAR D

  • Director
0 2019-10-11 0

COATS LONNEL PRESIDENT AND CEO

  • Officer
  • Director
227,539 2019-09-18 5

SANTINI ALEXANDER A EVP AND CCO

  • Officer
18,661 2019-09-18 3

BARKER SAM L

  • Director
52,187 2019-08-02 2

TESSMER JAMES F VP, FINANCE & ACCOUNTING

  • Officer
43,368 2019-08-02 3

AMOUYAL PHILIPPE

  • Director
0 2019-04-26 1

LEFKOWITZ ROBERT J MD

  • Director
0 2019-04-26 1

NIES ALAN S

  • Director
0 2019-04-26 1

PALANTONI FRANK

  • Director
0 2019-04-26 1

SWAIN JUDITH L

  • Director
0 2019-04-26 1

MAIN ALAN J EVP, COMMERCIAL SUPPLY OPS

  • Officer
67,067 2019-02-28 2

WADE JEFFREY L EVP, CORP ADM AFFAIRS AND CFO

  • Officer
72,508 2019-02-28 2

LAPUERTA PABLO EVP AND CMO

  • Officer
47,098 2019-02-28 2

TYLE PRAVEEN EVP, R&D

  • Officer
14,979 2019-02-28 2

INVUS PUBLIC EQUITIES, L.P.

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

STICHTING ADMINISTRATIEKANTOOR WESTEND

MINNE PASCAL

INVUS, L.P.

INVUS ADVISORS, L.L.C.

INVUS PUBLIC EQUITIES ADVISORS, LLC

  • Director
  • 10% Owner
60,240,864 2018-06-27 0

ARTAL INTERNATIONAL S.C.A.

ARTAL INTERNATIONAL MANAGEMENT S.A.

ARTAL GROUP S.A.

WESTEND S.A.

STICHTING ADMINISTRATIEKANTOOR WESTEND

MINNE PASCAL

  • 10% Owner
0 2018-05-23 0

INVUS C.V.

ULYS, L.L.C.

DEBBANE RAYMOND

  • Director
  • 10% Owner
30,283,190 2014-12-12 0

SANDS ARTHUR T PRESIDENT & CEO

  • Officer
  • Director
1,898,829 2014-02-28 0

ZAMBROWICZ BRIAN P EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
278,703 2014-02-28 0

ULYS, LLC

INVUS, L.P.

INVUS PUBLIC EQUITIES, LP

INVUS, CV

INVUS ADVISORS, L.L.C.

INVUS PUBLIC EQUITIES ADVISORS, LLC

DEBBANE RAYMOND

  • Director
  • 10% Owner
255,925,427 2011-12-22 3

ULYS, LLC

INVUS, L.P.

INVUS ADVISORS, L.L.C.

INVUS, CV

DEBBANE RAYMOND

  • 10% Owner
165,110,497 2010-03-19 3

TRAGASH STEVEN ALAN VP, CORPORATE AFFAIRS

  • Officer
0 2010-02-15 0

BROWN PHILIP M SVP, CLINICAL DEVELOPMENT

  • Officer
27,306 2010-02-12 0

WILTSEY KATHLEEN M

  • Director
0 2010-01-04 0

ULYS, LLC

INVUS, L.P.

INVUS ADVISORS, L.L.C.

DEBBANE RAYMOND

  • 10% Owner
70,840,291 2009-10-14 3

ISHIMOTO LANCE K SVP, INTELLECTUAL PROPERTY

  • Officer
0 2008-02-07 0

PIGGOTT JAMES R PHD SVP OF PHARM BIO

  • Officer
0 2008-02-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments